Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Effect of maintenance therapy (MT) on real-world outcomes (RWO) of patients (pts) with newly diagnosed multiple myeloma (NDMM) post stem cell transplant (SCT).

View Full Paper
Ask AI
Bookmark
Share

Authors

HPHarsh ParmarABAnna BarcellosNBNoa Biran

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Parmar et al. (2024) studied this question.

synapsesocial.com/papers/68e66db4b6db6435875f8699https://doi.org/10.1200/jco.2024.42.16_suppl.7562
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Real-world outcomes (RWO) with tandem transplantation in patients (pts) with newly diagnosed multiple myeloma (NDMM).2024
  2. 2Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis2026
  3. 3P54 | EVOLVING OUTCOMES IN MULTIPLE MYELOMA REAL-WORLD PRACTICE: 30-YEARS SINGLE CENTER EXPERIENCE2026
  4. 4Single versus double autologous stem cell transplantation and lenalidomide maintenance versus no maintenance therapy in newly-diagnosed patients with multiple myeloma: a real-life, vintage snapshot after twenty-three years from the Rete Ematologica Pugliese2025
  5. 589P Predictors of real-world (rw) outcomes in patients (pts) with advanced/metastatic (a/m) non-small cell lung cancer (NSCLC) treated with pembrolizumab-based maintenance (MT)2024